Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Press Release
Director Name Audit Committee Compensation Committee Nominating and Corporate Governance Committee Science and Technology Committee Alison Lawton Chairman of the Board member of Audit Committee chairperson of Nominating and Corporate Governance Committee Anne McGeorge chairperson of Audit Committee member of Nominating and Corporate Governance Committee Jonathan Violin, Ph.D. member of Science and Technology Committee Paula Soteropoulos member of Audit Committee chairperson of Compensation Committee Steven Romano, M.D. member of Compensation Committee chairperson of Science and Technology Committee Sujay Kango member of Compensation Committee Simon Read, Ph.D. member of Nominating and Corporate Governance Committee member of Science and Technology Committee Legend = Chairperson = Member = Chairman of the Board
